-
Taxonomy & unit
-
ifrs-full: CAD and USD
-
Summary
-
Clearmind Medicine Inc. quarterly/annual Research And Development Expense history and growth rate from Q4 2021 to Q4 2022.
- Clearmind Medicine Inc. Research And Development Expense for the quarter ending January 31, 2023 was CA$792K, a 86.8% increase year-over-year.
- Clearmind Medicine Inc. annual Research And Development Expense for 2022 was CA$4.21M, a 550% increase from 2021.
Research And Development Expense, Quarterly (CAD)
Research And Development Expense, YoY Quarterly Growth (%)